PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 56 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $131,000 | -61.8% | 119,261 | -52.3% | 0.00% | – |
| Q2 2020 | $343,000 | -52.4% | 250,235 | -60.4% | 0.00% | – |
| Q1 2020 | $720,000 | -59.8% | 631,668 | -19.6% | 0.00% | – |
| Q4 2019 | $1,792,000 | +1405.9% | 785,852 | +458.0% | 0.00% | – |
| Q3 2019 | $119,000 | -90.6% | 140,841 | -89.1% | 0.00% | – |
| Q2 2019 | $1,261,000 | -25.1% | 1,290,197 | -3.4% | 0.00% | – |
| Q1 2019 | $1,684,000 | -17.5% | 1,335,697 | +111.9% | 0.00% | – |
| Q4 2018 | $2,042,000 | +475.2% | 630,273 | +327.9% | 0.00% | – |
| Q3 2018 | $355,000 | -10.6% | 147,300 | +3.4% | 0.00% | – |
| Q2 2018 | $397,000 | -80.2% | 142,500 | -66.2% | 0.00% | – |
| Q1 2018 | $2,000,000 | +687.4% | 421,182 | +677.0% | 0.00% | – |
| Q2 2017 | $254,000 | +104.8% | 54,206 | +434.5% | 0.00% | – |
| Q4 2016 | $124,000 | – | 10,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,804,027 | $17,803,000 | 2.95% |
| HARBOURVEST PARTNERS LLC | 440,627 | $2,062,000 | 0.89% |
| NEA Management Company, LLC | 3,556,778 | $16,646,000 | 0.61% |
| Rock Springs Capital Management LP | 450,000 | $2,106,000 | 0.11% |
| Bain Capital Public Equity Management, LLC | 263,498 | $1,233,000 | 0.07% |
| ELEMENT CAPITAL MANAGEMENT LLC | 65,973 | $309,000 | 0.06% |
| Hillhouse Capital Management | 865,923 | $4,053,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 125,151 | $586,000 | 0.04% |
| Marshall Wace North America L.P. | 684,124 | $3,421,000 | 0.02% |
| FNY Partners Fund LP | 20,127 | $94,000 | 0.02% |